Advisor Group Holdings, Inc. Aravive, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.29 - $2.46 $741 - $1,414	575 New	575 $1,000
Q1 2022 May 04, 2022	SELL	$1.85 - $2.75 $4,197 - $6,239	-2,269 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$3.67 - $5.8 $2,429 - $3,839	662 Added 41.19%	2,269 $8,000
Q2 2021 Aug 02, 2021	BUY	$4.65 - $6.42 $4,663 - $6,439	1,003 Added 166.06%	1,607 $10,000
Q1 2021 May 13, 2021	BUY	$5.11 - $9.24 $3,086 - $5,580	604 New	604 $4,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.